论文部分内容阅读
目的研究中西结合治疗胰腺癌的临床效果。方法 85例胰腺癌患者,采用密封信封法分为A组(43例)和B组(42例)。A组采取西医吉西他滨联合顺铂(GP方案)化疗,B组在A组基础上采用中药治疗。对比两组胰腺癌治疗效果、治疗前后患者生存质量评分及生存期情况。结果 B组治疗总有效率为38.10%,A组治疗总有效率为32.56%,比较差异无统计学意义(P>0.05)。治疗后,B组生存质量评分为(83.18±8.71)分,优于A组的(75.43±6.29)分(P<0.05)。B组生存期为(3.42±1.12)年,长于A组的(2.04±0.56)年(P<0.05)。结论中西结合治疗胰腺癌的临床效果确切,可有效改善患者症状,改善其生存状况,值得推广应用。
Objective To study the clinical effect of combining traditional Chinese and western medicine on pancreatic cancer. Methods 85 patients with pancreatic cancer were divided into group A (43 cases) and group B (42 cases) by sealed envelope method. Group A received Western gemcitabine combined with cisplatin (GP regimen) chemotherapy, and Group B was treated with traditional Chinese medicine on the basis of Group A. Comparison of two groups of pancreatic cancer treatment effect, before and after treatment of patients with quality of life scores and survival. Results The total effective rate of group B was 38.10%, while the total effective rate of group A was 32.56%. There was no significant difference between the two groups (P> 0.05). After treatment, the quality of life in group B was (83.18 ± 8.71) points, which was better than that in group A (75.43 ± 6.29) (P0.05). The survival time of group B was (3.42 ± 1.12) years, longer than that of group A (2.04 ± 0.56) years (P <0.05). Conclusion The clinical effect of combining traditional Chinese and western medicine in the treatment of pancreatic cancer is exact, which can effectively improve the symptoms and improve the survival of patients and is worth popularizing and applying.